TRPV4-mediated calcium influx contributes temperature-dependent SARS-CoV-2 replication
PLOS Pathogens · 2026
DOI: 10.1371/journal.ppat.1014520 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, 2026. Verfasst von Moe Kobayashi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Viral Infection, Department of Infectious Disease Control, International Research Center for Infectious Diseases, Institute of Medical Sc…. Hauptthemen laut MEDLINE: TRPV Cation Channels, Virus Replication, SARS-CoV-2, Calcium. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development (AMED), Shionogi Infectious Disease Research Promotion Foundation, NOVARTIS Foundation (Japan) for the Promotion of Science.
Abstract (Originalsprache)
Temperature varies across the nasal cavity, lower respiratory tract, and during febrile conditions, yet the impact of these differences on SARS-CoV-2 replication remains poorly understood. Here, we show that ancestral SARS-CoV-2, Delta, or Omicron BA.5 variants replicate most efficiently at 37°C. We found that transient receptor potential vanilloid 4 (TRPV4)-mediated calcium influx, a thermosensitive cation channel known to be activated at 37°C, contributes to efficient SARS-CoV-2 replication. In addition, a calcineurin inhibitor, cyclosporine A (Cys A), and manidipine, an FDA-approved calcium channel blocker, both suppressed viral replication and protected Syrian hamsters from lethal infection with the SARS-CoV-2 Delta variant. Notably, a selective TRPV4 antagonist also conferred protection in infected hamsters. These results suggest that TRPV4-mediated calcium influx contributes to efficient SARS-CoV-2 replication at 37°C and highlight manidipine as a strong candidate for repurposing as an anti-SARS-CoV-2 therapeutic.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Viral Infection, Department of Infectious Disease Control, International Research Center for Infectious Diseases, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
- Department of Molecular Pathology, Graduate School of Medicine and Faculty of Medicine, The University of Tokyo, Tokyo, Japan.
- The University of Tokyo Pandemic Preparedness, Infection and Advanced Research Center (UTOPIA), The University of Tokyo, Tokyo, Japan.
ORCID-Profile: Takeshi Ichinohe
Förderung
- Japan Agency for Medical Research and Development (AMED)
- Shionogi Infectious Disease Research Promotion Foundation
- NOVARTIS Foundation (Japan) for the Promotion of Science
- JSPS KAKENHI
Zitieren
APA
Kobayashi, M., Abe, H., Sugihara, H., Kobayashi, N., Omori, S., Yamada, Y., & Ichinohe, T. (2026). TRPV4-mediated calcium influx contributes temperature-dependent SARS-CoV-2 replication. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1014520
Vancouver
Kobayashi M, Abe H, Sugihara H, Kobayashi N, Omori S, Yamada Y, et al. TRPV4-mediated calcium influx contributes temperature-dependent SARS-CoV-2 replication. PLOS Pathogens. 2026. doi:10.1371/journal.ppat.1014520
BibTeX
@article{Kobayashi2026,
author = {Kobayashi, Moe and Abe, Hatsumi and Sugihara, Hikaruko and Kobayashi, Nene and Omori, Seira and Yamada, Yasuhiro and Ichinohe, Takeshi},
title = {TRPV4-mediated calcium influx contributes temperature-dependent SARS-CoV-2 replication},
journal = {PLOS Pathogens},
year = {2026},
doi = {10.1371/journal.ppat.1014520}
}
EUVIMED